Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia

被引:79
|
作者
Stedehouder, J. [1 ]
Kushner, S. A. [1 ]
机构
[1] Erasmus Univ, Dept Psychiat, Med Ctr, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands
关键词
WHITE-MATTER ABNORMALITIES; GAMMA-AMINOBUTYRIC-ACID; DORSOLATERAL PREFRONTAL CORTEX; SOMATOSTATIN-IMMUNOREACTIVE NEURONS; MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; GABAERGIC NEURONS; 1ST-EPISODE SCHIZOPHRENIA; CEREBRAL-CORTEX; GABA NEURONS;
D O I
10.1038/mp.2016.147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Schizophrenia is a debilitating psychiatric disorder characterized by positive, negative and cognitive symptoms. Despite more than a century of research, the neurobiological mechanism underlying schizophrenia remains elusive. White matter abnormalities and interneuron dysfunction are the most widely replicated cellular neuropathological alterations in patients with schizophrenia. However, a unifying model incorporating these findings has not yet been established. Here, we propose that myelination of fast-spiking parvalbumin (PV) interneurons could be an important locus of pathophysiological convergence in schizophrenia. Myelination of interneurons has been demonstrated across a wide diversity of brain regions and appears highly specific for the PV interneuron subclass. Given the critical influence of fast-spiking PV interneurons for mediating oscillations in the gamma frequency range (similar to 30-120 Hz), PV myelination is well positioned to optimize action potential fidelity and metabolic homeostasis. We discuss this hypothesis with consideration of data from human postmortem studies, in vivo brain imaging and electrophysiology, and molecular genetics, as well as fundamental and translational studies in rodent models. Together, the parvalbumin interneuron myelination hypothesis provides a falsifiable model for guiding future studies of schizophrenia pathophysiology.
引用
收藏
页码:4 / 12
页数:9
相关论文
共 50 条
  • [1] Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia
    J Stedehouder
    S A Kushner
    Molecular Psychiatry, 2017, 22 : 4 - 12
  • [2] Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia
    Jiang, Zhihong
    Cowell, Rita M.
    Nakazawa, Kazu
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2013, 7
  • [3] Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia
    Lewis, David A.
    Curley, Allison A.
    Glausier, Jill R.
    Volk, David W.
    TRENDS IN NEUROSCIENCES, 2012, 35 (01) : 57 - 67
  • [4] Myelination of parvalbumin interneurons shapes the function of cortical sensory inhibitory circuits
    Najate Benamer
    Marie Vidal
    Maddalena Balia
    María Cecilia Angulo
    Nature Communications, 11
  • [5] Myelination of parvalbumin interneurons shapes the function of cortical sensory inhibitory circuits
    Benamer, Najate
    Vidal, Marie
    Balia, Maddalena
    Angulo, Maria Cecilia
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [6] Activity-Dependent Myelination of Parvalbumin Interneurons Mediated by Axonal Morphological Plasticity
    Stedehouder, Jeffrey
    Brizee, Demi
    Shpak, Guy
    Kushner, Steven A.
    JOURNAL OF NEUROSCIENCE, 2018, 38 (15): : 3631 - 3642
  • [7] Prefrontal cortex parvalbumin interneurons, FXR1, and schizophrenia
    不详
    NEUROSCIENTIST, 2021, 27 (05): : 453 - 453
  • [8] OXIDATIVE STRESS IN PARVALBUMIN INTERNEURONS IN A DEVELOPMENTAL RODENT MODEL OF SCHIZOPHRENIA
    O'Donnell, Patricio
    Do, Kim Q.
    Counotte, Danielle
    Cabungcal, JanHarry
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S28 - S28
  • [9] Conduction Velocity Along the Local Axons of Parvalbumin Interneurons Correlates With the Degree of Axonal Myelination
    Micheva, Kristina D.
    Kiraly, Marianna
    Perez, Marc M.
    Madison, Daniel, V
    CEREBRAL CORTEX, 2021, 31 (07) : 3374 - 3392
  • [10] Redox Dysregulation Affects Myelination and Parvalbumine Interneurons in Schizophrenia Models
    Do, Kim Q.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 284S - 284S